Literature DB >> 6540989

A digoxin-like immunoreactive substance in preeclampsia.

J P Gusdon, V M Buckalew, J F Hennessy.   

Abstract

A study has been undertaken of levels of an endogenous substance which immunologically cross reacts with digoxin and may be the putative natriuretic hormone. The possibility that this substance may play a role in the pathophysiology of preeclampsia has been studied by measuring the plasma concentrations in clinically healthy and preeclamptic pregnant patients. A significant difference (p less than 0.001) between these two groups has been found.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6540989     DOI： 10.1016/s0002-9378(84)80114-3

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN： 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Endogenous factors with immunological and biological activity similar to cardiac glycosides: biochemical and pathophysiological implications.

Authors:  A Clerico; G Mariani
Journal:  J Endocrinol Invest       Date:  1992-05       Impact factor: 4.256

2.  DigiFab interacts with endogenous cardiotonic steroids and reverses preeclampsia-induced Na/K-ATPase inhibition.

Authors:  Valentina V Ishkaraeva-Yakovleva; Olga V Fedorova; Nelly G Solodovnikova; Elena V Frolova; Anton M Bzhelyansky; Igor V Emelyanov; C David Adair; Irina E Zazerskaya; Alexei Y Bagrov
Journal:  Reprod Sci       Date:  2012-05-30       Impact factor: 3.060

3.  The sodium pump and hypertension: a physiological role for the cardiac glycoside binding site of the Na,K-ATPase.

Authors:  Jack H Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

Review 4.  Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets.

Authors:  Alexei Y Bagrov; Joseph I Shapiro; Olga V Fedorova
Journal:  Pharmacol Rev       Date:  2009-03       Impact factor: 25.468

Review 5.  Sodium transport inhibitors in pregnancy-induced hypertension.

Authors:  L Poston
Journal:  Cardiovasc Drugs Ther       Date:  1990-03       Impact factor: 3.727

Review 6.  Circulating digitalis-like factors.

Authors:  V M Buckalew
Journal:  Pediatr Nephrol       Date:  1988-04       Impact factor: 3.714

Review 7.  Principles of drug biodisposition in the neonate. A critical evaluation of the pharmacokinetic-pharmacodynamic interface (Part II).

Authors:  J B Besunder; M D Reed; J L Blumer
Journal:  Clin Pharmacokinet       Date:  1988-05       Impact factor: 6.447

8.  Endogenous digoxin-like immunoreactivity during pregnancy and at birth.

Authors:  J M Lupoglazoff; E Jacqz-Aigrain; B Guyot; O Chappey; P Blot
Journal:  Br J Clin Pharmacol       Date:  1993-03       Impact factor: 4.335

9.  Interaction of Digibind with endogenous cardiotonic steroids from preeclamptic placentae.

Authors:  Olga V Fedorova; Natalia I Tapilskaya; Anton M Bzhelyansky; Elena V Frolova; Elena R Nikitina; Vitaly A Reznik; Vladimir A Kashkin; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2010-02       Impact factor: 4.844

10.  Magnesium sulfate potentiates effect of DigiFab on marinobufagenin-induced Na/K-ATPase inhibition.

Authors:  Irina E Zazerskaya; Valentina V Ishkaraeva; Elena V Frolova; Nelly G Solodovnikova; Yulia N Grigorova; C David Adair; Olga V Fedorova; Alexei Y Bagrov
Journal:  Am J Hypertens       Date:  2013-07-22       Impact factor: 2.689
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.